CEO: Jeffrey D. Marrazzo

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Spark Therapeutics Inc is a gene therapy company. The company is engaged in developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases.


Key numbers

Market Capitalization:4286926790
Shares Outstanding: 37747000
Float: 34804395
Next Earning Date:
TTm EPS: -6.5447
TTm Dividend Rate:
200 days moving average:105.73
50 days moving average: 108.13
One day percent Change: 2.55



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,